Wyeth Prevenar
Executive Summary
Pneumococcal conjugate vaccine has been recommended by the Centers for Disease Control & Prevention Advisory Committee on Immunization Practices, contingent on approval of the vaccine by FDA and review of any additional safety and efficacy data. Prevenar is scheduled for review by an FDA advisory committee Nov. 5